Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS

Abstract Background The aims of this study were to compare the efficacy of different androgens measured by liquid chromatography-mass spectrometry (LC-MS/MS) in representing hyperandrogenemia and to evaluate adrenal-origin androgens with a dexamethasone suppression test in patients with polycystic o...

Full description

Bibliographic Details
Main Authors: Fu Chen, Minjie Chen, Weichun Zhang, Huihuang Yin, Guishan Chen, Qingxia Huang, Xiaoping Yang, Lan Chen, Chujia Lin, Guoshu Yin
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-021-00781-5
_version_ 1797972249389563904
author Fu Chen
Minjie Chen
Weichun Zhang
Huihuang Yin
Guishan Chen
Qingxia Huang
Xiaoping Yang
Lan Chen
Chujia Lin
Guoshu Yin
author_facet Fu Chen
Minjie Chen
Weichun Zhang
Huihuang Yin
Guishan Chen
Qingxia Huang
Xiaoping Yang
Lan Chen
Chujia Lin
Guoshu Yin
author_sort Fu Chen
collection DOAJ
description Abstract Background The aims of this study were to compare the efficacy of different androgens measured by liquid chromatography-mass spectrometry (LC-MS/MS) in representing hyperandrogenemia and to evaluate adrenal-origin androgens with a dexamethasone suppression test in patients with polycystic ovary syndrome (PCOS). Methods One hundred and two patients with PCOS and 41 healthy volunteers were recruited and total serum testosterone (TT), androstenedione (AD), dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S) were measured by LC-MS/MS. ROC analysis was performed to compare the efficacy of different androgens in representing hyperandrogenemia. Dexamethasone suppression test was performed in 51 patients with PCOS and above indicators were measured after dexamethasone administration. The prediction efficacy of DHEA and DHEA-S at baseline in the dexamethasone suppression test was evaluated with ROC analysis. Results The AUCs of TT, AD, free androgen index (FAI) and DHEA-S in ROC analysis for representing hyperandrogenemia were 0.816, 0.842, 0.937 and 0.678, respectively. The optimal cutoff value of TT was 0.337 ng/ml, with a sensitivity of 72.0% and specificity of 82.93%. The optimal cutoff value for AD was 1.309 ng/ml, with a sensitivity of 81.0% and specificity of 73.17%. The optimal cutoff value of the FAI was 2.50, with a sensitivity of 87.0% and specificity of 92.68%. Alternatively, AD or FAI more than the optimal cutoff values as evidence of hyperandrogenemia had the highest sensitivity of 91.18%. The levels of cortisol, DHEA and DHEA-S were all suppressed to narrow ranges after dexamethasone administration. Nine and 8 of 51 patients with PCOS had significant decreases in TT and AD, respectively. DHEA can be used as a indicator for predicting significant decrease of TT in dexamethasone suppression test with cutoff value of 13.28 ng/ml. A total of 27.5% (14/51) of patients had DHEA-S excess, but only 1 of 9 patients who had a significant decrease in TT had elevated level of DHEA-S at baseline. Conclusions AD measured by LC-MS/MS can represent hyperandrogenemia in PCOS patients and, combined with TT or FAI, can improve the screening efficiency of hyperandrogenemia. Seventeen percent of PCOS patients had adrenal-origin androgen dominance, with TT significantly decreasing after 2 days of dexamethasone administration. Adrenal-origin androgen dominance was not parallel with DHEA-S excess in patients with PCOS.
first_indexed 2024-04-11T03:44:25Z
format Article
id doaj.art-95a5e127bd384348b58449414d98d263
institution Directory Open Access Journal
issn 1757-2215
language English
last_indexed 2024-04-11T03:44:25Z
publishDate 2021-02-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj.art-95a5e127bd384348b58449414d98d2632023-01-02T02:58:39ZengBMCJournal of Ovarian Research1757-22152021-02-011411910.1186/s13048-021-00781-5Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOSFu Chen0Minjie Chen1Weichun Zhang2Huihuang Yin3Guishan Chen4Qingxia Huang5Xiaoping Yang6Lan Chen7Chujia Lin8Guoshu Yin9Department of Clinical Nutrition, The 1st Affiliated Hospital of Shantou University Medical CollegeDepartment of Endocrinology, The 1st Affiliated Hospital of Shantou University Medical CollegeDepartment of Endocrinology, The 1st Affiliated Hospital of Shantou University Medical CollegeDepartment of Endocrinology, The 1st Affiliated Hospital of Shantou University Medical CollegeDepartment of Endocrinology, The 1st Affiliated Hospital of Shantou University Medical CollegeDepartment of Endocrinology, The 1st Affiliated Hospital of Shantou University Medical CollegeDepartment of Endocrinology, The 1st Affiliated Hospital of Shantou University Medical CollegeDepartment of Endocrinology, The 1st Affiliated Hospital of Shantou University Medical CollegeDepartment of Endocrinology, The 1st Affiliated Hospital of Shantou University Medical CollegeDepartment of Endocrinology, The 1st Affiliated Hospital of Shantou University Medical CollegeAbstract Background The aims of this study were to compare the efficacy of different androgens measured by liquid chromatography-mass spectrometry (LC-MS/MS) in representing hyperandrogenemia and to evaluate adrenal-origin androgens with a dexamethasone suppression test in patients with polycystic ovary syndrome (PCOS). Methods One hundred and two patients with PCOS and 41 healthy volunteers were recruited and total serum testosterone (TT), androstenedione (AD), dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S) were measured by LC-MS/MS. ROC analysis was performed to compare the efficacy of different androgens in representing hyperandrogenemia. Dexamethasone suppression test was performed in 51 patients with PCOS and above indicators were measured after dexamethasone administration. The prediction efficacy of DHEA and DHEA-S at baseline in the dexamethasone suppression test was evaluated with ROC analysis. Results The AUCs of TT, AD, free androgen index (FAI) and DHEA-S in ROC analysis for representing hyperandrogenemia were 0.816, 0.842, 0.937 and 0.678, respectively. The optimal cutoff value of TT was 0.337 ng/ml, with a sensitivity of 72.0% and specificity of 82.93%. The optimal cutoff value for AD was 1.309 ng/ml, with a sensitivity of 81.0% and specificity of 73.17%. The optimal cutoff value of the FAI was 2.50, with a sensitivity of 87.0% and specificity of 92.68%. Alternatively, AD or FAI more than the optimal cutoff values as evidence of hyperandrogenemia had the highest sensitivity of 91.18%. The levels of cortisol, DHEA and DHEA-S were all suppressed to narrow ranges after dexamethasone administration. Nine and 8 of 51 patients with PCOS had significant decreases in TT and AD, respectively. DHEA can be used as a indicator for predicting significant decrease of TT in dexamethasone suppression test with cutoff value of 13.28 ng/ml. A total of 27.5% (14/51) of patients had DHEA-S excess, but only 1 of 9 patients who had a significant decrease in TT had elevated level of DHEA-S at baseline. Conclusions AD measured by LC-MS/MS can represent hyperandrogenemia in PCOS patients and, combined with TT or FAI, can improve the screening efficiency of hyperandrogenemia. Seventeen percent of PCOS patients had adrenal-origin androgen dominance, with TT significantly decreasing after 2 days of dexamethasone administration. Adrenal-origin androgen dominance was not parallel with DHEA-S excess in patients with PCOS.https://doi.org/10.1186/s13048-021-00781-5Polycystic ovary syndrome (PCOS)Dexamethasone suppression testAndrogenAdrenalLiquid chromatography-mass spectrometry (LC-MS/MS)
spellingShingle Fu Chen
Minjie Chen
Weichun Zhang
Huihuang Yin
Guishan Chen
Qingxia Huang
Xiaoping Yang
Lan Chen
Chujia Lin
Guoshu Yin
Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS
Journal of Ovarian Research
Polycystic ovary syndrome (PCOS)
Dexamethasone suppression test
Androgen
Adrenal
Liquid chromatography-mass spectrometry (LC-MS/MS)
title Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS
title_full Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS
title_fullStr Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS
title_full_unstemmed Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS
title_short Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS
title_sort comparison of the efficacy of different androgens measured by lc ms ms in representing hyperandrogenemia and an evaluation of adrenal origin androgens with a dexamethasone suppression test in patients with pcos
topic Polycystic ovary syndrome (PCOS)
Dexamethasone suppression test
Androgen
Adrenal
Liquid chromatography-mass spectrometry (LC-MS/MS)
url https://doi.org/10.1186/s13048-021-00781-5
work_keys_str_mv AT fuchen comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos
AT minjiechen comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos
AT weichunzhang comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos
AT huihuangyin comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos
AT guishanchen comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos
AT qingxiahuang comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos
AT xiaopingyang comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos
AT lanchen comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos
AT chujialin comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos
AT guoshuyin comparisonoftheefficacyofdifferentandrogensmeasuredbylcmsmsinrepresentinghyperandrogenemiaandanevaluationofadrenaloriginandrogenswithadexamethasonesuppressiontestinpatientswithpcos